拉丁美洲人群新冠后肺纤维化管理中的挑战
Challenges in the Management of Post-COVID-19 Pulmonary Fibrosis for the Latin American Population.
作者信息
Cherrez-Ojeda Ivan, Cortés-Telles Arturo, Gochicoa-Rangel Laura, Camacho-Leon Génesis, Mautong Hans, Robles-Velasco Karla, Faytong-Haro Marco
机构信息
School of Health, Universidad de Especialidades Espíritu Santo, Samborondón 0901952, Guayas, Ecuador.
Respiralab Research Group, Guayaquil 090512, Guayas, Ecuador.
出版信息
J Pers Med. 2022 Aug 27;12(9):1393. doi: 10.3390/jpm12091393.
Abstract
This commentary aims to highlight some of the major issues (with possible solutions) that the Latin American region is currently dealing with in managing post-COVID-19 pulmonary fibrosis. Overall, there is little evidence for successful long-term COVID-19 follow-up treatment. The lack of knowledge regarding proper treatment is exacerbated in Latin America by a general lack of resources devoted to healthcare, and a lack of availability and access to multidisciplinary teams. The discussion suggests that better infrastructure (primarily multicenter cohorts of COVID-19 survivors) and well-designed studies are required to develop scientific knowledge to improve treatment for the increasing prevalence of pulmonary fibrosis in Latin America.
摘要
本评论旨在强调拉丁美洲地区目前在管理新冠后肺纤维化方面正在应对的一些主要问题（以及可能的解决方案）。总体而言，几乎没有证据表明新冠长期随访治疗取得成功。由于普遍缺乏用于医疗保健的资源，以及缺乏多学科团队的可及性和服务，拉丁美洲对适当治疗的认识不足问题更加严重。讨论表明，需要更好的基础设施（主要是新冠幸存者的多中心队列）和精心设计的研究，以发展科学知识，改善拉丁美洲日益普遍的肺纤维化治疗。
相似文献
1
Challenges in the Management of Post-COVID-19 Pulmonary Fibrosis for the Latin American Population.
J Pers Med. 2022 Aug 27;12(9):1393. doi: 10.3390/jpm12091393.
2
The 2023 Latin America report of the Countdown on health and climate change: the imperative for health-centred climate-resilient development.
Lancet Reg Health Am. 2024 Apr 23;33:100746. doi: 10.1016/j.lana.2024.100746. eCollection 2024 May.
3
Obesity and COVID-19 in Latin America: A tragedy of two pandemics-Official document of the Latin American Federation of Obesity Societies.
Obes Rev. 2021 Mar;22(3):e13165. doi: 10.1111/obr.13165. Epub 2020 Nov 23.
4
Position statement of the Latin American Dysphagia Society for the management of oropharyngeal and esophageal dysphagia during the COVID-19 pandemic.
Rev Gastroenterol Mex (Engl Ed). 2022 Jan-Mar;87(1):63-79. doi: 10.1016/j.rgmxen.2021.12.004. Epub 2021 Dec 29.
5
Predictors of COVID-19 Fatality: A Worldwide Analysis of the Pandemic over Time and in Latin America.
J Epidemiol Glob Health. 2022 Jun;12(2):150-159. doi: 10.1007/s44197-022-00031-x. Epub 2022 Jan 14.
6
The SARS-CoV-2 Pandemic in Latin America: the Need for Multidisciplinary Approaches.
Curr Trop Med Rep. 2020;7(4):120-125. doi: 10.1007/s40475-020-00219-w. Epub 2020 Nov 3.
7
A Narrative Review of Telemedicine in Latin America during the COVID-19 Pandemic.
Healthcare (Basel). 2022 Jul 22;10(8):1361. doi: 10.3390/healthcare10081361.
8
Pre-existing conditions in Latin America and factors associated with adverse outcomes of COVID-19: A review.
Medwave. 2021 May 4;21(4):e8181. doi: 10.5867/medwave.2021.04.8180.
9
Effect of COVID-19 on patient access to health services for noncommunicable diseases in Latin America: a perspective from patient advocacy organizations.
Int J Equity Health. 2022 Apr 2;21(1):45. doi: 10.1186/s12939-022-01648-x.
10
COVID-19 and Multisystem Inflammatory Syndrome in Latin American Children: A Multinational Study.
Pediatr Infect Dis J. 2021 Jan;40(1):e1-e6. doi: 10.1097/INF.0000000000002949.
引用本文的文献
1
GPR40 activation alleviates pulmonary fibrosis by repressing M2 macrophage polarization through the PKD1/CD36/TGF-β1 pathway.
Acta Pharmacol Sin. 2025 May 14. doi: 10.1038/s41401-025-01558-y.
2
Impact of Pulmonary Comorbidities on COVID-19: Acute and Long-Term Evaluations.
J Clin Med. 2025 Feb 21;14(5):1446. doi: 10.3390/jcm14051446.
3
Long-Term Lung Sequelae in Survivors of Severe/Critical COVID-19 Pneumonia: The "Non-Steroid", "Non-Interventional" Approach.
J Clin Med. 2025 Jan 8;14(2):347. doi: 10.3390/jcm14020347.
4
Association between age people started working and missing teeth in an elderly population in Ecuador: Evidence from a cross-sectional study.
PLoS One. 2023 Nov 13;18(11):e0293635. doi: 10.1371/journal.pone.0293635. eCollection 2023.
5
The influence of a quick educational video intervention on COVID-19-related knowledge in Ecuador.
PLoS One. 2023 Oct 5;18(10):e0291709. doi: 10.1371/journal.pone.0291709. eCollection 2023.
6
Small airway disease in post-acute COVID-19 syndrome, a non-conventional approach in three years follow-up of a patient with long COVID: a case report.
J Med Case Rep. 2023 Sep 11;17(1):386. doi: 10.1186/s13256-023-04113-7.
7
Pharmacological approaches to pulmonary fibrosis following COVID-19.
Front Pharmacol. 2023 Jun 15;14:1143158. doi: 10.3389/fphar.2023.1143158. eCollection 2023.
本文引用的文献
1
Persistent Pneumonic Consolidations due to Secondary Organizing Pneumonia in a Patient Recovering from COVID-19 Pneumonia: A Case Report and Literature Review.
Infect Chemother. 2023 Mar;55(1):121-127. doi: 10.3947/ic.2022.0128. Epub 2023 Jan 9.
2
A Narrative Review of Telemedicine in Latin America during the COVID-19 Pandemic.
Healthcare (Basel). 2022 Jul 22;10(8):1361. doi: 10.3390/healthcare10081361.
3
Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study.
EClinicalMedicine. 2022 Jul 18;51:101549. doi: 10.1016/j.eclinm.2022.101549. eCollection 2022 Sep.
4
Provision of pulmonary rehabilitation in Latin America 18 months after the COVID-19 pandemic: A survey of the Latin American Thoracic Association.
Chron Respir Dis. 2022 Jan-Dec;19:14799731221104102. doi: 10.1177/14799731221104102.
5
Physician's attitudes on pulmonary rehabilitation following COVID-19: a brief perspective from a developing country.
Multidiscip Respir Med. 2022 Apr 14;17(1):837. doi: 10.4081/mrm.2022.837. eCollection 2022 Jan 12.
6
Post-acute Sequelae in COVID-19 Survivors: an Overview.
SN Compr Clin Med. 2022;4(1):91. doi: 10.1007/s42399-022-01172-7. Epub 2022 Apr 6.
7
Post COVID-19 pulmonary fibrosis; a meta-analysis study.
Ann Med Surg (Lond). 2022 May;77:103590. doi: 10.1016/j.amsu.2022.103590. Epub 2022 Apr 6.
8
Post-COVID-19 Pulmonary Fibrosis.
Cureus. 2022 Mar 2;14(3):e22770. doi: 10.7759/cureus.22770. eCollection 2022 Mar.
9
Air trapping in COVID-19 patients following hospital discharge: retrospective evaluation with paired inspiratory/expiratory thin-section CT.
Eur Radiol. 2022 Jul;32(7):4427-4436. doi: 10.1007/s00330-022-08580-2. Epub 2022 Feb 28.
10
Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia.
Front Med (Lausanne). 2022 Jan 31;8:823600. doi: 10.3389/fmed.2021.823600. eCollection 2021.
Zotero 插件